Patient Guide: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 110 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06425159
Status: 🟢 Enrolling Now
Condition: Generalized Epilepsy
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 110 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Phoenix, Arizona
  • • Phoenix, Arizona
  • • And 107 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures - Join Clinical Trial NCTNCT06425159

How to Join This Clinical Trial - NCTNCT06425159

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Generalized Epilepsy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Generalized Epilepsy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Generalized Epilepsy
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06425159 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 110 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35244 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85013 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85015 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85718 - United States

Status: RECRUITING

Clinical Research Site

Rogers, Arkansas 72758 - United States

Status: WITHDRAWN

Clinical Research Site

Lancaster, California 93534 - United States

Status: WITHDRAWN

Clinical Research Site

Pasadena, California 91105 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20010 - United States

Status: RECRUITING

Clinical Research Site

Bradenton, Florida 34209 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32209 - United States

Status: RECRUITING

And 100 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Generalized Epilepsy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships